-
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. DC CAFC
- 1:19-cv-02100
- D. Del.
- Judge: Mitchell S. Goldberg
- Filed: 11/05/2019
- Closed: 02/10/2023
- Latest Docket Entry: 05/30/2023
- PACER
2
Plaintiffs
1
Defendant
1
Accused
Product
7
Patents-in-Suit
1,194
Days in
Litigation
-
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. DC CAFC
- 1:19-cv-02100
- D. Del.
- Judge: Mitchell S. Goldberg
- Filed: 11/05/2019
- Closed: 02/10/2023
- Latest Docket Entry: 05/30/2023
- PACER
Causes of Action
Infringement
Declaratory Judgment
Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
Patent Information
-
Infringement
Alkem Laboratories Limited
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic version of Silvergate’s Epaned® Product | US 10,786,482 B2 | All Asserted Claims |
No infringement
Entry 214
|
| Generic version of Silvergate’s Epaned® Product | US 10,918,621 B2 | All Asserted Claims |
No infringement
Entry 214
|